A carregar...
A Rational Designed Novel Bispecific Antibody for the Treatment of GBM
Epidermal growth factor receptor variant III (EGFRvIII) is highly and specifically expressed in a subset of lethal glioblastoma (GBM), making the receptor a unique therapeutic target for GBM. Recently, bispecific antibodies (BsAbs) have shown exciting clinical benefits in cancer immunotherapy. Here,...
Na minha lista:
| Publicado no: | Biomedicines |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8230177/ https://ncbi.nlm.nih.gov/pubmed/34204931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9060640 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|